TRANSCRIPT TO FOLLOW
The information contained within is for educational and informational purposes ONLY. It is not intended nor should it be considered an invitation or inducement to buy or sell a security or securities noted within nor should it be viewed as a communication intended to persuade or incite you to buy or sell security or securities noted within. Any commentary provided is the opinion of the author and should not be considered a personalised recommendation. The information contained within should not be a person's sole basis for making an investment decision. Please contact your financial professional before making an investment decision.
China shares have had their worst October in a decade, and the sell-off yesterday was the larg...
T Rowe Price's Chris Alderson explains why stock market performance is diverging - and what in...
Trying to time the stock market will only result in capital loss says Morningstar Investment M...
Service sector data much better than expected in the latest data, helped by economic recovery in ...
VIDEO: Raheel Altaf, portfolio manager of the Artemis SmartGARP Global Emerging Markets Equity Fu...
Mining companies are operating in a challenging environment but could now be the time to top up o...
THE WEEK: Morningstar columnist Rodney Hobson provides two pieces of advice to George Osborne, an...
Businesses that have competitive advantages within their industry are good candidates for dividen...
Morningstar reveals the top 10 best performers over the last five years
Morningstar OBSR reveals the top funds for investors seeking exposure to European equities
Here’s what to expect from the latest key data release as the ECB prepares to cut rates
We are raising our fair value estimate for the stock, which now looks fairly valued after the lat...
The Cambridge-based cyber security firm is set to be taken over by US private equity firm Thoma B...
Equity funds have not seen quarterly inflows since 2021, but March's figures do show some moderat...
We are raising our fair value estimate for the stock after impressive results
Adam Fleck, CFA Adam Fleck is an associate director of research with Morningstar.